Day One Biopharmaceuticals, Inc. (DAWN)
NASDAQ: DAWN · Real-Time Price · USD
6.21
+0.07 (1.14%)
At close: Aug 13, 2025, 4:00 PM
6.21
0.00 (0.00%)
Pre-market: Aug 14, 2025, 8:42 AM EDT
Accolade Market Cap
DAWN has a market cap or net worth of $636.10 million as of August 14, 2025. Its market cap has decreased by -52.61% in one year.
Market Cap
636.10M
Enterprise Value
186.00M
1-Year Change
-52.61%
Ranking
Category
Stock Price
$6.21
Market Cap Chart
Since the IPO on May 27, 2021, DAWN's market cap has decreased from $965.40M to $636.10M, a decrease of -34.11%. That is a compound annual growth rate of -9.42%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 13, 2025 | 636.10M | -50.22% |
| Dec 31, 2024 | 1.28B | 0.54% |
| Dec 29, 2023 | 1.27B | -19.71% |
| Dec 30, 2022 | 1.58B | 51.68% |
| Dec 31, 2021 | 1.04B | 8.09% |
| May 27, 2021 | 965.40M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 570.26B |
| Johnson & Johnson | 418.62B |
| AbbVie | 350.91B |
| AstraZeneca | 229.47B |
| UnitedHealth Group | 228.94B |
| Novartis AG | 228.69B |
| Abbott Laboratories | 228.63B |
| Novo Nordisk | 222.88B |